Last Updated: 16 Sep 2024
Executive Summary
Liquidia Technologies Inc. (LQDA), a biopharmaceutical company, is currently trading at $9.8. With a market capitalization of $826.48 million, the company has experienced a -0.235% quarterly revenue growth and a 0% quarterly earnings growth. Despite a strong analyst rating, the company's financial ratios indicate challenges, including a negative EBITDA, EPS, and return on assets and equity.
Company Overview
Liquidia Technologies develops and commercializes products for unmet patient needs. Headquartered in North Carolina, the company's focus on respiratory and rare diseases has led to the development of products like Inbrija, a dry powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Fundamental Analysis
Financial Ratios:
EBITDA: -$95.83 million
EPS: -$1.58
Return on Assets: -0.407%
Return on Equity: -1.817%
Revenue and Earnings:
Revenue TTM: $14.84 million
Quarterly Revenue Growth YOY: -0.235%
Quarterly Earnings Growth YOY: 0%
Valuation Metrics:
Price-to-Sales Ratio TTM: 55.69
Price-to-Book Ratio: 13.18
Technical Analysis
Moving Averages:
50-Day Moving Average: $11.06
200-Day Moving Average: $12.35
Support and Resistance Levels:
Support: $9.50
Resistance: $10.50
Short Term Outlook
Technically, LQDA is facing resistance at $10.50. If it fails to break this level, it could fall back to support at $9.50. The 50-day moving average is acting as a support level, indicating potential upside in the short term.
Long Term Outlook
The company's negative financial ratios and weak revenue growth are concerns for its long-term prospects. However, the strong analyst rating suggests that analysts see potential in the company's pipeline and future growth opportunities.
Analyst Recommendations
Strong Buy: 4
Buy: 2
Hold: 1
Sell: 0
Strong Sell: 0
Conclusion
Liquidia Technologies is a speculative stock with both upside potential and risks. Its negative financial ratios and weak revenue growth raise concerns, but the strong analyst rating and potential for future growth opportunities warrant consideration. Investors should carefully weigh the risks and rewards before making an investment decision.
